ConductScience.org, home

Paper41006729

Long term anticoagulation for Catheter-Related deep vein thrombosis of the upper extremities in women with cancer: retrospective analysis of effectiveness and safety outcomes.

Cavallaro C and 11 others. J Thromb Thrombolysis, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Long term anticoagulation for Catheter-Related deep vein thrombosis of the upper extremities in women with cancer: retrospective analysis of effectiveness and safety outcomes. Papers, record 41006729. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41006729

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long term anticoagulation for Catheter-Related deep vein thrombosis of the upper extremities in women with cancer: retrospective analysis of effectiveness and safety outcomes.
PubMed
Journal
J Thromb Thrombolysis
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-12-28
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cavallaro CChiara
2Santini PPaolo
3Leoni LLaura
4Mosoni CCarolina
5D'Ambrosio SSilvia
6Mancinetti FFrancesco
7Coletta NNicola
8Iorio MMichela
9Porfidia AAngelo
10D'Errico AAlessandro
11Talerico RRosa
12Pola RRoberto

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticoagulantsMajor topic
Upper Extremity Deep Vein ThrombosisMajor topic
NeoplasmsMajor topic
Central Venous CathetersMajor topic
Humans
Female
Retrospective Studies
Middle Aged
Aged
Treatment Outcome
Hemorrhage
Adult
Recurrence
Time Factors
Upper Extremity

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112484710Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.Ann Intern Med2002https://conductscience.org/library/papers/12484710PubMed
226407753Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.J Thromb Haemost2015https://conductscience.org/library/papers/26407753PubMed
335837602A Single Center Retrospective Cohort Study Comparing Different Anticoagulants for the Treatment of Catheter-Related Thrombosis of the Upper Extremities in Women With Gynecologic and Breast Cancer.Front Cardiovasc Med2022https://conductscience.org/library/papers/35837602PubMed
423252176Reducing upper extremity deep vein thrombosis when inserting PICCs.Br J Nurs2012https://conductscience.org/library/papers/23252176PubMed
538065528Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis.J Thromb Haemost2024https://conductscience.org/library/papers/38065528PubMed
620434007Bleeding complications associated with anticoagulant therapy in patients with cancer.Thromb Res2010https://conductscience.org/library/papers/20434007PubMed
736774305Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism.Eur J Intern Med2023https://conductscience.org/library/papers/36774305PubMed
88775526Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications.Aust N Z J Med1996https://conductscience.org/library/papers/8775526PubMed
928316279Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.N Engl J Med2017https://conductscience.org/library/papers/28316279PubMed
1026314776Central venous access in oncology: ESMO Clinical Practice Guidelines.Ann Oncol2015https://conductscience.org/library/papers/26314776PubMed
1137075273Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.J Clin Oncol2023https://conductscience.org/library/papers/37075273PubMed
1235114046Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up.J Thromb Haemost2022https://conductscience.org/library/papers/35114046PubMed
1326992301A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis.J Vasc Surg Venous Lymphat Disord2015https://conductscience.org/library/papers/26992301PubMed
1434816583Extended anticoagulation treatment for cancer-associated thrombosis-Rates of recurrence and bleeding beyond 6 months: A systematic review.J Thromb Haemost2022https://conductscience.org/library/papers/34816583PubMed
1540162636Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.N Engl J Med2025https://conductscience.org/library/papers/40162636PubMed
1623697825Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.Lancet2013https://conductscience.org/library/papers/23697825PubMed
1723216615Apixaban for extended treatment of venous thromboembolism.N Engl J Med2013https://conductscience.org/library/papers/23216615PubMed
1821366477Clinical practice. Deep-vein thrombosis of the upper extremities.N Engl J Med2011https://conductscience.org/library/papers/21366477PubMed
1933570602American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.Blood Adv2021https://conductscience.org/library/papers/33570602PubMed
2025680892A systematic review of patient-related risk factors for catheter-related thrombosis.J Thromb Thrombolysis2015https://conductscience.org/library/papers/25680892PubMed

See all 35 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42724952
Inflammation-coagulation biomarkers predict catheter-related thrombosis following peripherally inserted central catheter placement in patients with hematologic malignancies: a retrospective cohort study.
Transl Cancer Res2026https://conductscience.org/library/papers/42724952PubMed
42194892Risk Factors for Catheter-Related Thrombosis.J Clin Med2026https://conductscience.org/library/papers/42194892PubMed
41405755Thrombosis in patients with cancer: challenges and advances.J Thromb Thrombolysis2025https://conductscience.org/library/papers/41405755PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41006729

GET https://conductscience.org/api/papers/v1/41006729/references?page=2